Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 310

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy

Open access
Geller, Eric B., Skarpaas, Tara L., Gross, Robert E., Goodman, Robert R., Barkley, Gregory L., Bazil, Carl W., Berg, Michael J., Bergey, Gregory K., Cash, Sydney S., Cole, Andrew J., Duckrow, Robert B., Edwards, Jonathan C., Eisenschenk, Stephan, Fessler, James, Fountain, Nathan B., Goldman, Alicia M., Gwinn, Ryder P., Heck, Christianne, Herekar, Aamar, Hirsch, Lawrence J., Jobst, Barbara C., King‐Stephens, David, Labar, Douglas R., Leiphart, James W., Marsh, W. Richard, Meador, Kimford J., Mizrahi, Eli M., Murro, Anthony M., Nair, Dileep R., Noe, Katherine H., Park, Yong D., Rutecki, Paul A., Salanova, Vicenta, Sheth, Raj D., Shields, Donald C., Skidmore, Christopher, Smith, Michael C., Spencer, David C., Srinivasan, Shraddha, Tatum, William, Van Ness, Paul C., Vossler, David G., Wharen, Robert E., Worrell, Gregory A., Yoshor, Daniel, Zimmerman, Richard S., Cicora, Kathy, Sun, Felice T., Morrell, Martha J.·2017·Epilepsia

Abstract

Summary: Objective: Evaluate the seizure‐reduction response and safety of mesial temporal lobe (MTL) brain‐responsive stimulation in adults with medically intractable partial‐onset seizures of mesial temporal lobe origin. Methods: Subjects with mesial temporal lobe epilepsy (MTLE) were identified from prospective clinical trials of a brain‐responsive neurostimulator (RNS System, NeuroPace). The seizure reduction over years 2–6 postimplantation was calculated by assessing the seizure frequency compared to a preimplantation baseline. Safety was assessed based on reported adverse events. Results: There were 111 subjects with MTLE; 72% of subjects had bilateral MTL onsets and 28% had unilateral onsets. Subjects had one to four leads placed; only two leads could be connected to the device. Seventy‐six subjects had depth leads only, 29 had both depth and strip leads, and 6 had only strip leads. The mean follow‐up was 6.1 ± (standard deviation) 2.2 years. The median percent seizure reduction was 70% (last observation carried forward). Twenty‐nine percent of subjects experienced at least one seizure‐free period of 6 months or longer, and 15% experienced at least one seizure‐free period of 1 year or longer. There was no difference in seizure reduction in subjects with and without mesial temporal sclerosis (MTS), bilateral MTL onsets, prior resection, prior intracranial monitoring, and prior vagus nerve stimulation. In addition, seizure reduction was not dependent on the location of depth leads relative to the hippocampus. The most frequent serious device‐related adverse event was soft tissue implant‐site infection (overall rate, including events categorized as device‐related, uncertain, or not device‐related: 0.03 per implant year, which is not greater than with other neurostimulation devices). Significance: Brain‐responsive stimulation represents a safe and effective treatment option for patients with medically intractable epilepsy, including patients with unilateral or bilateral MTLE who are not candidates for temporal lobectomy or who have failed a prior MTL resection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/epi.13740

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 310

Metadata

Authors
Geller, E. B., Skarpaas, T. L., Gross, R. E., Goodman, R. R., Barkley, G. L., Bazil, C. W., Berg, M. J., Bergey, G. K., Cash, S. S., Cole, A. J., Duckrow, R. B., Edwards, J. C., Eisenschenk, S., Fessler, J., Fountain, N. B., Goldman, A. M., Gwinn, R. P., Heck, C., Herekar, A., Hirsch, L. J., Jobst, B. C., King‐Stephens, D., Labar, D. R., Leiphart, J. W., Marsh, W. R., Meador, K. J., Mizrahi, E. M., Murro, A. M., Nair, D. R., Noe, K. H., Park, Y. D., Rutecki, P. A., Salanova, V., Sheth, R. D., Shields, D. C., Skidmore, C., Smith, M. C., Spencer, D. C., Srinivasan, S., Tatum, W., Van Ness, P. C., Vossler, D. G., Wharen, R. E., Worrell, G. A., Yoshor, D., Zimmerman, R. S., Cicora, K., Sun, F. T., & Morrell, M. J.
Venue
Epilepsia
Publisher
Wiley
Published
2017-04-11
Volume
58
Issue
6
Pages
994-1004
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2607074866
Cited by
310
References
38
FWCI
23.71
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy. https://app.cochat.ai/papers/10.1111/epi.13740
The paper
Geller, E. B., Skarpaas, T. L., Gross, R. E., Goodman, R. R., Barkley, G. L., Bazil, C. W., Berg, M. J., Bergey, G. K., Cash, S. S., Cole, A. J., Duckrow, R. B., Edwards, J. C., Eisenschenk, S., Fessler, J., Fountain, N. B., Goldman, A. M., Gwinn, R. P., Heck, C., Herekar, A., . . . Morrell, M. J. (2017). Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy. Epilepsia. https://doi.org/10.1111/epi.13740

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.